⌘K

Login Start Free

Home/Filings/4/0000950170-25-032141

4//SEC Filing

Dube Michael P 4

Accession 0000950170-25-032141

CIK 0001652130other

View on SEC.gov Company Profile

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:28 PM ET

Size

4.7 KB

Accession

0000950170-25-032141

Insider Transaction Report

Form 4

Period: 2025-03-01

Intellia Therapeutics, Inc.NTLA

VP, Chief Accounting Officer

Transactions

Award
Common Stock
2025-03-01+14,000→ 59,640 total

Footnotes (1)

[F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Intellia Therapeutics, Inc.

CIK 0001652130

Entity typeother

Related Parties

1

filerCIK 0002019493

Filing Metadata

Form type: 4
Filed: Mar 3, 7:00 PM ET
Accepted: Mar 4, 4:28 PM ET
Size: 4.7 KB

View on SEC.gov